Vaccine, AstraZeneca, Tesla, Regeneron: 5 Things You Must Know


Here are five things you must know for Monday, Nov. 23:

1. — Stock Futures Rise on Vaccine Progress

Stock futures rose Monday as investors welcomed further progress on the development of a coronavirus vaccine but were hard-pressed to ignore rising infection rates and curbs on businesses that could hamper an economic recovery.

Contracts linked to the Dow Jones Industrial Average were up 204 points, S&P 500 futures gained 22 points and Nasdaq futures rose 50 points.

The Covid-19 vaccine candidate being developed by AstraZeneca  (AZN) – Get Report and the University of Oxford was found in a large trial to have prevented a majority of people from getting the disease.

Meanwhile, Moncef Slaoui, the chief scientific adviser for Operation Warp Speed, said some Americans could start receiving a Covid-19 vaccine by mid-December.

The positive developments come as cases of Covid-19, the disease caused by the coronavirus, topped 12.2 million in the U.S. over the weekend, according to Johns Hopkins University, and deaths in the U.S. approached 257,000.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *